Toxicology Recap Flashcards
Label the diagram about drug plasma levels.
A= Toxic range
B = Therapeutic range
C= Subtherapeutic range
D = minimum effective concentration
E = maximum effective concentration
Explain the difference between efficacy of a drug and potency.
Give an example.
Efficacy is the maximum effect a drug can have
Potency is the amount of drug required to get a given amount of efficacy/response.
For example, Buprenex is a very low dose required compared to methadone to get a small amount of pain control so is very potent.
However, it is not very efficacious- pure mu opioids will give a much higher level of pain control when given at full doses.
Explain the following diagram, including what each of the letters indicates.
- This diagram shows the difference between giving a loading dose and just starting routine dosing of a medication.
- At the top (dotted line- A), a loading dose was given so the drug quickly reaches therapeutic levels.
- At the bottom (solid line) routine dosing of the medication was started.
- At point B, the initial peak level for the first dose (Peak 0), therapeutic levels were not reached.
- It is not until point C that therapeutic levels are first reached and sustained through the entire dosing interval (after 9 doses in this instance).
- Point D indicates steady state (overall curve is no longer rising, peak levels are consistent from dose to dose).
- It takes 3 to 5 half lives for a drug to reach steady state.
- Drugs with long-half lives should typically be loaded if they need to be immediately effective (phenobarbital 50 hours or KBr 24 days).
- Drugs with short half-lives do not usually need to be loaded (keppra 2-4 hours).
Define Therapeutic index.
ratio of adverse event EC50 to the therapeutic effect EC50.
The larger the index, the safer the drug
Define Bioavailability
The percentage of an administered dose that reaches systemic circulation
Define first pass metabolism
The amount of a drug that is metabolized before it reaches circulation (ie in the GI tract or liver).
Define enterohepatic recirculation
when a drug is metabolized by the liver, re-excreted in bile, and then reabsorbed again by the GI tract. This can prolong the activity of the drug since it is not immediately eliminated.
Define elimination half life
The time necessary for half the drug to be eliminated from the body. It takes 5 half lives to eliminate 97% of a drug.
Define volume of distribution.
- Theoretical volume in which the total amount of drug would need to be distributed to produce the desired blood concentration. AKA the amount of tissue to which a drug is distributed.
- There are high and low volume of distribution drugs
- VD affects half life- smaller VD – lower rate of elimination
Explain high volume of distribution drugs.
lipid soluble (non-polar), easily enter cells/tissues.
Low rates of ionization, low plasma binding
Explain low volume of distribution drugs.
water soluble (polar)
high rates of ionization, high plasma binding
Name 4 reasons to avoid inducing emesis:
- Corrosive agent, (bleach, batteries, lye)
- Hydrocarbon toxicant (kerosene, gasoline)
- Symptomatic patients (neurologic in any way, agitated, weak, collapsed, hypoglycemic)
- Patients at risk for aspiration pneumonia (megaesophagus, lar par)
Name the 7 toxins that do NOT bind to activated charcoal
- Ethylene glycol
- Xylitol
- Ethanol/other alcohols
- Hydrocarbons (petroleum distillates, etc)
- Metals (lead, coper, iron, arsenic, lithium)
- Inorganic toxins (cyanide, ammonia, nitrates, nitrites, phosphorus, bromide)
- Corrosive/caustic agents
Name some possible complications of activated charcoal administration.
- Aspiration
- Electrolyte changes- most concerning is hypernatremia which can be fatal due to hyperosmolarity
- Dehydration
- Constipation/impaction
Is multiple dose charcoal administration recommended in humans? Are cathartics recommended in humans.
Multiple dose charcoal and cathartics are not recommended in humans per the toxicology position statements.
List the 2 main theories for the mechanism of action of intralipids in toxicology.
Improves myocardial function
Lipid sink theory
Discuss the theory that intralipids improve myocardial function.
- FFA are the preferred energy source of myocardial energy production
- Increase intracellular calcium
- Alpha adrenergic recpetor mediated increased vasopressor effect
- Reduction of NO and insulin induced vasodilation
Discuss the lipid sink theory for intralipids
Lipophilic compounds are compartmentalized intravascularly preventing drug absorption into tissue decreasing toxic effects
Discuss Organophosphates and Aldicarb.
MOA:
Clinical signs:
MOA: Inhibit acetylcholinesterase causing parasympathetic stimulation
CS:
Muscarinic: SLUDGE, bronchorrhea
Nicotinic: tremors/twitching
Discuss Bromethalin.
MOA:
Clinical signs:
MOA: Inhibits oxidative phosphorylation in CNS -> malfunction of ATP dependent ion pumps -> cerebral edema
CS: Tremors, seizures, coma, death
Discuss Ivermectin.
MOA:
Clinical signs:
MOA:
Agonist of glutamate-activated inhibitory chloride channels in invertebrates.
At high concentrations it stimulates Gaba-A channels in mammals -> hyperpolarization of cell membranes -> no depolarization.
CS: Ataxia, weakness, blindness, mydriasis, GI upset, bradycardia, coma, hypoventilation, seizures, death
Discuss Pyrethrins.
MOA:
Clinical signs:
MOA: Disrupts voltage-sensitive Na channels -> easier or extended depolarization.
CS: Muscle tremors/seizures, hypersalivation, hyperesthesia
Discuss Strichnine.
MOA:
Clinical signs:
MOA: Inhibits the inhibitory neurotransmitter glyceine in the inhibitory interneurons (renshaw cells) in the spinal cord -> net excitatory effect on all striated muscles
CS: Generalized rigidity and tonic-clonic seizures
Explain the 3 stages of ethylene glycol toxicity including duration after ingestion, what is happening in the body, clinical signs, and possible treatment options at each stage.
Stage 1:
- 0.5-12 hrs
- Due to EG itself
- GI upset, PU/PD, ataxia, muscle fasciculations, high AG, metabolic acidosis, hyperosmolarity, crystalluria.
- This is potentially reversible- prior to metabolite formation. Treat with ethanol or 4-MP to prevent metabolite formation or with dialysis to remove EG and metabolites before they cause ARF.
Stage 2:
- 8-24 hrs
- Most signs resolve, tachycardia/tachypnea, depression. Metabolites are doing their thing.
- Likely not treatable by this point.
Stage 3:
- 24-72 hrs
- Depression, decreased UOP, vomiting, seizures, halitosis/oral ulcers, azotemia → Anuria.
- Can try dialysis for weeks until kidneys possibly heal, but mostly doomed
Name a few tremorgenic mycotoxins
- penitrem-A
- roquefortine C
- verruculogen
- aflatrem
- thomitrems
- cyclopiazonic acid
Draw a basic chart showing the phospholipid pathway and where NSAIDS and steroids work.